CD30 Ligand / TNFSF8蛋白產(chǎn)品信息

別名: TNFSF8
表達(dá)方式: 
A DNA sequence encoding the rat TNFSF8 (Gln66-Asp237) was expressed with two additional amino acids (Gly & Pro) at the N-terminus.
種屬: Rat
表達(dá)宿主: Human Cells

CD30 Ligand / TNFSF8 Protein QC Testing

純度: > 95 % as determined by SDS-PAGE SDS-PAGE
內(nèi)**: < 1.0 EU per μg of the protein as determined by the LAL method
穩(wěn)定性: Samples are stable for up to twelve months from date of receipt at -70℃
預(yù)測(cè)N端: Gly
分子量: 
The recombinant rat TNFSF8 comprises 174 amino acids and predicts a molecular mass of 19.6 kDa. The apparent molecular mass of  the recombinant protein is approximately 31-35 kDa in SDS-PAGE under reducing conditions due to glycosylation.
緩沖液: Lyophilized from sterile PBS, pH 7.4.
Normally 5 % - 8 % trehalose and mannitol are added as protectants before lyophilization. Specific concentrations are included in the hardcopy of COA.
Please contact us for any concerns or special requirements.

CD30 Ligand / TNFSF8 Protein Usage Guide

儲(chǔ)存方法: Store it under sterile conditions at -70℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
Reconstitution: A hardcopy of COA with reconstitution instruction is sent along with the products. Please refer to it for detailed information.

CD30 Ligand / TNFSF8蛋白背景綜述

CD30 ligand (CD30L), also known as CD153 and TNFSF8, is a cytokine belonging to the emerging tumor necrosis factor (TNF) ligand superfamily, and is a specific ligand for CD30/ TNFRSF8 originally described as a cell surface antigen and a marker for Hodgkin lymphoma and related hematologic malignancies. CD30L is a type-II membrane glycoprotein expressed on activated T cells, stimulated monocyte-macrophages, granulocytes, eosinophils, and some Burkitt-like lymphoma cell lines. CD30L is capable of transducing signals through CD30 on different CD30+ lymphoma cell lines, and mediates pleiotropic biologic effects including cell proliferation, activation, differentiation, as well as cell death by apoptosis. CD30-CD30 ligand interaction has been suggested to have a pathophysiologic role in malignant lymphomas, particularly Hodgkin disease, large cell anaplastic lymphomas and Burkitt lymphomas, and is also involved in activation and functioning of the T cell-dependent immune response.

參考文獻(xiàn)

Gruss HJ. et al.,1994, Blood. 83: 2045-56.
Croager EJ. et al., 1997, Biochim Biophys Acta. 1353: 231-5.
Wendtner CM. et al., 1995, Cancer Res. 55: 4157-61.
Fischer M. et al., 2006, J Clin Invest. 116: 2748-56.
Blazar BR. et al., 2004, J Immunol. 173: 2933-41.

規(guī)格：50ug

關(guān) 鍵 詞：Rat CD30 Ligand / TNFSF8 Protein,使用說(shuō)明,現(xiàn)貨，實(shí)驗(yàn)室耗材，生化試劑，上海創(chuàng)賽，博飛美科，實(shí)驗(yàn)儀器，廠家

CANSPEC品質(zhì)提供的Rat CD30 Ligand / TNFSF8 Protein|使用說(shuō)明|現(xiàn)貨性能**，其優(yōu)良的品質(zhì)滿(mǎn)足您不同實(shí)驗(yàn)的多種需求。

本產(chǎn)品由上海創(chuàng)賽品質(zhì)提供，歡迎咨詢(xún)國(guó)內(nèi)免費(fèi)服務(wù)專(zhuān)線：400-608-7598，更多產(chǎn)品信息請(qǐng)登錄www.ahbcpqn.cn 或 www.4006087598.com